Peptide Blog

Protirelin (TRH Thyrotropin) is a synthetic analog peptide of the naturally occurring thyrotropin-releasing hormone (TRH). It comprises three amino acids and is considered by scientists to be released by the brain's hypothalamus region. As such, it is classified as a neuropeptide with potential neuromodulation characteristics. This peptide has also been studied for its potential to...

Thymosin Alpha 1 (Tα1) is a naturally occurring peptide initially isolated from thymus. It comprises 28 amino acids manifesting varied biological potential. These are considered to be highly diverse, including immune response augmentation, strengthening vaccine efficacy, and overcoming chemotherapy-induced and other toxicities. Besides this, the peptide may be relevant in research related to cancers like...

Tesamorelin, Modified GRF 1-29, and Ipamorelin represent a cohort of synthetic peptides with disparate mechanisms, converging on the probable stimulation of growth hormone (GH) synthesis and secretion. Tesamorelin, functioning as a synthetic analogue of growth hormone-releasing hormone (GHRH), appears to exhibit a distinctive potential to elicit the production and release of endogenous growth hormone (GH)....

Semaglutide peptide is a novel glucagon-like peptide-1 (GLP-1) receptor agonist. It has emerged as an innovative compound within the realm of type 2 diabetes mellitus and obesity research. This article provides an overview of Semaglutide, its proposed mechanism of action, essential functions, historical development, and research data. Semaglutide peptide is a synthetic analog of glucagon-like...

B7-33, a monomeric peptide, represents a synthetic derivation in soluble form from the endogenous protein H2-relaxin. This innovative peptide appears to retain the intrinsic anti-fibrotic attributes of relaxin, and researchers suggest it may strategically avoid the upregulation of cyclic adenosine monophosphate (cAMP) production. Beyond these foundational proposed characteristics, B7-33 appears to exhibit the unique potential...

Scientific investigations have suggested that the blend of GHRP-2 and CJC-1295 peptides may be associated with the activation of discrete receptors, fostering the potential augmentation of growth hormone (GH) discharge from the anterior pituitary. CJC-1295 represents a molecular entity that appears to exhibit a binding affinity for the growth hormone-releasing hormone (GHRH) receptors, thereby potentially...

Tesamorelin and Ipamorelin represent two distinct synthetic growth hormone-releasing peptides (GHRPs) that have garnered considerable attention in the realm of biochemical research. Both compounds, Tesamorelin and Ipamorelin, appear to possess the potential to stimulate the release of endogenous growth hormone (GH) through the activation of the ghrelin receptor. This unique action has spurred increasing scientific...

GHK, a tripeptide constituting the amino acid sequence glycine-histidine-lysine, appears to be ubiquitously found in plasma, saliva, and urine, exhibiting an age-related decline. In the context of plasma, GHK concentrations are suggested to be present at levels of approximately 200 ng/mL during early adulthood; however, these concentrations are speculated to diminish to approximately 80 ng/mL...

Thymosin Beta 4 (TB4) is a naturally occurring peptide. It consists of 43 amino acids and research suggests that it may appear in high concentrations in various cell lines, including blood platelets and lymphocytes. Synthetic Thymosin Beta 4 is also known as TB-500. Research studies suggest that Thymosin Beta 4 may exhibit some potential to...